Cargando…
Dissolution and pharmacokinetics of a novel micronized aspirin formulation
Aspirin (acetylsalicylic acid, ASA) has been used as an analgesic, antipyretic and antiinflammatory drug for many years. A new 500 mg aspirin tablet formulation containing micronized active ingredient and an effervescent component has been developed for potential improvement in the onset of action f...
Autores principales: | Voelker, M., Hammer, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SP Birkhäuser Verlag Basel
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398252/ https://www.ncbi.nlm.nih.gov/pubmed/22057729 http://dx.doi.org/10.1007/s10787-011-0099-z |
Ejemplares similares
-
Influence of Differing Analgesic Formulations of Aspirin on Pharmacokinetic Parameters
por: Kanani, Kunal, et al.
Publicado: (2015) -
Evaluation of onset of pain relief from micronized aspirin in a dental pain model
por: Cooper, S. A., et al.
Publicado: (2012) -
Influence of the Efavirenz Micronization on Tableting and Dissolution
por: Pinto, Eduardo Costa, et al.
Publicado: (2012) -
Efavirenz Dissolution Enhancement I: Co-Micronization
por: da Costa, Maíra Assis, et al.
Publicado: (2012) -
Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation
por: Angiolillo, Dominick J., et al.
Publicado: (2022)